Insider: Miller Laurie A. SVP, Human Resources - HAEMONETICS CORP
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 12,697 | 0 | 12,697 |
| Value | $605,265.99 | $0.00 | $605,265.99 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 09/19/2022 | DDS | 212 | Direct | COM | $76.25 | $16,165.00 | 12,697 |
| 07/05/2022 | DDS | 42 | Direct | COM | $66.18 | $2,779.56 | 12,909 |
| 06/13/2022 | DDS | 30 | Direct | COM | $62.60 | $1,878.00 | 12,951 |
| 06/02/2022 | DDS | 198 | Direct | COM | $62.69 | $12,412.62 | 12,981 |
| 05/19/2022 | DDS | 91 | Direct | COM | $59.10 | $5,378.10 | 13,179 |
| 05/16/2022 | DDS | 31 | Direct | COM | $56.10 | $1,739.10 | 10,232 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research